1 June 2023 in Nature Neuroscience
SHStephanie Holstein-Rønsbo
Stephanie Holstein-Rønsbo
+5
20 September 2023 in Journal of The Royal Society Interface
SHStephanie Holstein-Rønsbo
Stephanie Holstein-Rønsbo
The flow of cerebrospinal fluid (CSF) along perivascular spaces (PVSs) is an important part of the brain’s system for clearing metabolic waste. Experiments reveal that arterial motions from cardiac pulsations and functional hyperaemiadrive CSF in the same direction as the blood flow, but the mechanism producing this directionality is unclear. Astrocyte endfeet bound the PVSs of penetrating arteries, separating them from brain extracellular space (ECS) and potentially regulating flow between the two compartments. Here, we present two models, one based on the full equations of fluid dynamics and the other using lumped parameters, in which the astrocyte endfeet function as valves, regulating flow between the PVS and the ECS. In both models, cardiac pulsations drive a net CSF flow consistent with prior experimental observations. Functional hyperaemia, acting with cardiac pulsation, increases the net flow. We also find, in agreement with experiments, a reduced net flow during wakefulness, due to the known decrease in ECS permeability compared to the sleep state. We present in vivo imaging of penetrating arteries in mice, which we use to measure accurately the amplitude of their constrictions and dilations during both cardiac pulsation and functional hyperaemia, an important input for the models. Our models can be used to explore the effects of changes in other input parameters, such as those caused by ageing or disease, as better measurements of these parameters become available.
3 April 2024 in Journal of The Royal Society Interface
The flow of cerebrospinal fluid (CSF) along perivascular spaces (PVSs) is an important part of the brain’s system for clearing metabolic waste. Astrocyte endfeet bound the PVSs of penetrating arteries, separating them from brain extracellular space. Gaps between astrocyte endfeet might provide a low-resistance pathway for fluid transport across the wall. Recent studies suggest that the astrocyte endfeet function as valves that rectify the CSF flow, producing the net flow observed in pial PVSs by changing the size of the gaps in response to pressure changes. In this study, we quantify this rectification based on three features of the PVSs: the quasi-circular geometry, the deformable endfoot wall, and the pressure oscillation inside. We provide an analytical model, based on the thin-shell hoop-stress approximation, and predict a pumping efficiency of about 0.4, which would contribute significantly to the observed flow. When we add the flow resistance of the extracellular space (ECS) to the model, we find an increased net flow during sleep, due to the known increase in ECS porosity (decreased flow resistance) compared to that in the awake state. We corroborate our analytical model with three-dimensional fluid–solid interaction simulations.
2 December 2025 in Journal of Experimental Medicine
Alzheimer’s disease (AD) is characterized by the accumulation of extracellular aggregated amyloid beta, resulting from impaired waste clearance. We recently identified new cerebrospinal fluid (CSF) efflux structures termed arachnoid cuff exit (ACE) points and speculated that these may be impacted in AD, leading to impaired waste clearance function. Using 5XFAD mice, we found progressive amyloidosis of bridging veins at ACE points. Indeed, in 5XFAD mice, there is impaired CSF efflux to the dura mater, impaired CSF flow along bridging veins, and impaired blood flow through bridging veins. These observations suggest that ACE point amyloidosis plays a role in waste clearance dysfunction in AD. In postmortem human samples, we also found striking amyloidosis of the bridging veins of individuals with AD. Moreover, in human AD specimens, there was prominent bridging vein structural degeneration, indicating advanced pathology and stronger deficits in humans. We propose that bridging vein amyloidosis is an underrecognized pathophysiological correlate of AD that may impair CSF efflux, intracranial pressure, vascular reactivity, and vascular integrity.
12 November 2025 in Physical Review Letters
Solute transport in a channel has important implications in industrial processes, biomechanics, and drug delivery. When flow is driven down a channel by a pressure gradient, solute is spread axially by shear and laterally by molecular diffusion. The combination causes the effective axial diffusivity to exceed the molecular diffusivity, a phenomenon known as Taylor dispersion. Here we show, however, that if the channel walls are permeable to the fluid but not to the solute, solute in the channel can be consolidated, making the effective axial diffusivity negative, a phenomenon we call "antidispersion." We present a theoretical model, with numerical validation, to study antidispersion, demonstrating that it occurs both with boluses of solute and with moving solute fronts. We determine the conditions in which antidispersion exceeds dispersion: high dimensionless permeability, moderate dimensionless flow speed, and concentration gradients that are not too steep. Our findings may inform understanding of biological circulation systems and design of systems for controlling solute concentration, as in drug delivery and desalination.
11 February 2026 in Journal of The Royal Society Interface
The flow of cerebrospinal fluid (CSF) through the perivascular spaces (PVSs) and interstitial fluid (ISF) in the extracellular space (ECS) is important for brain waste removal and drug delivery. The circulation of this flow is often called the glymphatic system. We build on an existing hydraulic network model of steady flow in this system to enable the study of time-dependent flows, allowing the modelling of the processes of tracer injection and drug delivery in the glymphatic network. Using flow rates from the steady-state model and the method of Laplace transforms, we solve this time-dependent advection–diffusion equation for the network semi-analytically and show that the solution closely matches numerical simulations. We find that a particular value of the endfoot gap cavity fraction maximizes solute perfusion. Furthermore, we find that a smaller gap fraction around PVS segments at the brain surface and a larger gap fraction around deeper PVS segments produce more uniform perfusion, which is consistent with a previous study (Wang et al. 2021 Glia69, 715–728 (doi:10.1002/glia.23923)). We also observe that greater permeability of the ECS improves perfusion, and that tracers with lower diffusivity exhibit enhanced perfusion.